BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Leukemia
,
Hypothalamus
,
Pharmacogenetics
,
VEGFA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
mk 906
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast adenocarcinoma SKBR3 cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Comparison of gene expression in LNCaP prostate cancer cells after treatment with bicalutamide or 5-…
Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells.
Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates…
5 alpha-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue she…
Effect of long-term administration of finasteride (MK-906), an inhibitor of 5 alpha-reductase, in pa…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency (MK-3682B-0…
Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of MK-8666 in Participants With Type 2 …
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-1029 in Participants With Mil…
A Study to Assess the Safety, Tolerability and Glucose-Lowering Efficacy of MK-0893 in Participants …
Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ